Inosine supplementation has no effect on aerobic or anaerobic cycling performance

International Journal of Sport Nutrition

Volumn 9, Issue 4, 1999, Pages 333-344

  McNaughton, Lars ^a   Dalton, Brad ^b   Tarr, Janine ^b  

^a KINGSTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

2,3 DPG; Ergogenic effects; High intensity exercise; Time trialing; Uric acid

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; INOSINE; URIC ACID;

ADULT; ARTICLE; ATHLETE; BICYCLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENERGY METABOLISM; EXERCISE; HUMAN; MALE; OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE; URINALYSIS;

EID: 0033396557     PISSN: 10501606     EISSN: None     Source Type: Journal    
DOI: 10.1123/ijsn.9.4.333     Document Type: Article

References (18)

1. Brooke, M., R. Choksi, and K. Kaiser. Inosine monophosphaite production is proportional to muscle force invitro. Neurology. 36:288-291, 1986.
2. Cobbin, L.B., E. Einstein, and M.H. Maguire. Studies on the coronary dilator actions of some adenosine analogues. Br. J. Pharmacol. 50:25-33, 1974.
3. De Verdier, C.H., and M. Westman. Intravenous infusion of Inosine in man: effect of erythrocyte 2,3 diphosphoglycerate concentration and on blood oxygen affinity. Scand. J. Clin. Lab. Invest. 32:205-210, 1973.
4. Dudley, G., and R. Terjung. Influence of aerobic metabolism on IMP accumulation in fast-twitch muscle. Am. J. Physiol. 238:C37-C42, 1985.
5. Gledhill, N. Blood doping and related issues: a brief review. Med. Sci. Sports Exerc. 14:183-189, 1982.
6. Harmsen, E., P.P. de Tombe, J. de Jong, and P.W. Achterberg. Enhanced ATP and GTP synthesis from hypoxanthine or inosine after myocardial ischemia. Am. J. Physiol. 246: H37-H43, 1984.
7. Jones, C.E., and L.R. Meyer. Nonmetabolically coupled coronary vasodilation during inosine infusion in dogs. Am. J. Physiol. 238:H569-G574, 1980.
8. Jones, C.E., L.R. Meyer, E.E. Smith, and T. W. Hurst. Relaxation of the isolated coronary artery by inosine: non-involvement of the adenosine receptor. J. Cardiovas. Pharmacol. 15:862-867, 1990.
9. Juhasz-Nagy, A., and D.M. Aviado. Inosine as a cardiotonic agent that reverses adrenergic beta blockade. J.Pharmacol. Exp. Ther. 202:683-695, 1977.
10. Lowenstein, J. M. The purine nucleotide cycle revised. Int. J. Sports Med. 11:S37-S46, 1990.
11. Powers, F.M., P.A. Sobotka, and J.X. Thomas, Jr. Effect of Inosine in the normal and reperfused rat heart. J. Cardiovas. Pharmacol. 15:862-867, 1990.
12. Reubin, E., and J. L. Farber. Pathophysiology (2nd ed.) Philadelphia: Lippincott, 1988.
13. Starling, R.D., T.A. Trappe, K.R. Short, M. Sheffield-Moore, A.C. Jozosi, W.J. Fink, and D.L. Costill. Effect of Inosine supplementation on aerobic and anaerobic cycling performance. Med. Sci. Sports Exerc. 28:1193-1198, 1996.
14. Tullson, P.C., and R.L. Terjung, Adenine nucleotide degradation in striated muscle. Int. J. Sports Med. 11:S47-S55, 1990.
15. Valeri, C.R. Blood Banking and the Use of Frozen Blood Products. Cleveland: CRC Press, 1976.
16. Westra, H., A. Dehaan, J. Van Doom, and E. Dehaan. IMP production and energy metabolism during exercise in relation to age. Biochem. J. 239:751-755, 1986.
17. Williams, M.H. Ergogenic and ergolytic substances. Med. Sci. Sports. Exerc. 24:344-348, 1992.
18. 2 peak. Med. Sci.Sports Exerc. 22:517-522, 1990.